argenx SE reported 33.43 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
AstraZeneca 24.63 0.71 Sep/2026
Genmab 16.04 1.05 Jun/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
GRIFOLS 13.04 1.66 Sep/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lakefront Biotherapeutics 2.68 0.14 Jun/2026
Qiagen NV 23.09 6.37 Sep/2026
UCB 29.7 5.52 Dec/2025